Seres Therapeutics, Inc. Notes Payable, Noncurrent
Seres Therapeutics, Inc. (MCRB) had Notes Payable, Noncurrent of $0 as of 2024-12-31, per its 10-K filed 2025-03-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermNotesPayable · last filed 2025-03-13
- 2024-12-31: Notes Payable, Noncurrent $0.00.
- 2024-09-30: Notes Payable, Noncurrent $0.00.
- 2024-06-30: Notes Payable, Noncurrent $102.49M.
- 2024-03-31: Notes Payable, Noncurrent $102.01M.
| Period end | Notes Payable, Noncurrent |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-13 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-13 |
| 2024-06-30 | $102.49M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $102.01M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $101.54M 10-K · filed 2025-03-13 |
| 2023-09-30 | $101.14M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $100.74M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $51.23M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $50.59M 8-K · filed 2024-08-15 |
| 2022-09-30 | $50.86M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $50.63M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $50.44M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $24.64M 10-K · filed 2023-03-07 |
| 2021-09-30 | $16.12M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $19.04M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $21.87M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $24.64M 10-K · filed 2022-03-01 |
| 2020-09-30 | $24.98M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $24.86M 10-Q · filed 2020-07-28 |
| 2020-03-31 | $24.75M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $24.65M 10-K · filed 2021-03-02 |
| 2015-06-30 | $727.00K 10-Q · filed 2015-08-10 |
| 2014-12-31 | $1.30M 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |